Heart and liver xenotransplantation under low-dose tacrolimus: Graft survival after withdrawal of immunosuppression

Transplantation

Volumn 71, Issue 2, 2001, Pages 217-223

  Molleví, David G ^a   Ribas, Yolanda ^a   Morell Ginesta, Mireia ^a   Serrano, Teresa ^b   Mestre, Mariona ^b   Vidal, August ^b   Figueras, Joan ^a   Jaurrieta, Eduardo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HAMSTER; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LIVER TRANSPLANTATION; LYMPHOCYTE; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; XENOGRAFT; XENOTRANSPLANTATION;

EID: 0035956735     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200101270-00008     Document Type: Article

References (23)

1. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis
2. Immunoglobulin prevents complement mediated hyperacute rejection in swine-to-primate xenotransplantation
3. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection
4. The control of hyperacute rejection by genetic engineering of the donor species
5. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model
6. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production
7. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs
8. Modification of humoral responses by the combination of leflunomide and cyclosporine in Lewis rats transplanted with hamster hearts
9. Genetic control of the humoral immune response to xenografts: Functional characterization of rat monoclonal antibodies to hamster heart xenografts
10. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model
11. Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts
12. Accommodation of vascularized xenografts: Expression of protective genes by donor endothelial cells in a host Th2 cytokine environment
13. Mechanisms of injury in porcine livers perfused with blood of humans with fulminant hepatic failure
14. Immunopathology of liver transplantation
15. Interactions between liver allografts and lymphocytotoxic antibodies in inbred rats
16. Improved technique of heart transplantation in rats
17. Orthotopic liver transplantation in the rat: Technique using cuff for portal vein anastomosis and biliary drainage
18. Survival of accommodated cardiac xenografts upon retransplantation into cyclosporine-treated recipients
19. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection
20. FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation
21. Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific
22. Long-term survival of hamster-to-rat cardiac xenografts in the absence of a Th2 shift
23. Heart allografts in murine systems: The differential activation of Th2-like effector cells in peripheral tolerance